Approval · Notice of Compliance 12561 · 2011
OVIDREL: Notice of Compliance 12561
Issued August 10, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12561
- Date
- August 10, 2011
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Presentation
- Therapeutic class
- Gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OVIDREL | 02371588 | Marketed |
Medicinal ingredients
- CHORIOGONADOTROPIN ALFA 250 MCG per CART